SHEHNAAZ SULIMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SHEHNAAZ SULIMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SHEHNAAZ SULIMAN. SHEHNAAZ SULIMAN is Director in Ultragenyx Pharmaceutical Inc. ($RARE) and SVP, Corp Dev & Strategy in Theravance Biopharma, Inc. ($TBPH) and President and COO in Alector, Inc. ($ALEC) and Director in 10x Genomics, Inc. ($TXG).
Latest Insider Trading Transactions of SHEHNAAZ SULIMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TXG, ALEC, TBPH, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2020 | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | President and COO | Option Exercise | A | 10.24 | 189,213 | 1,937,541 | 189,213 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Grant | A | 0.00 | 2,550 | 0 | 5,550 | 3 K to 5.6 K (+85.00 %) |
| Jun 17 2020 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 88.42 | 4,432 | 391,877 | 4,432 | |
| Jan 27 2020 | ALEC | Alector, Inc. | SULIMAN SHEHNAAZ | President and COO | Option Exercise | A | 17.23 | 550,000 | 9,476,500 | 550,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | J | 30.00 | 100,000 | 3,000,000 | 100,000 | |
| Sep 16 2019 | TXG | 10x Genomics, Inc. | SULIMAN SHEHNAAZ | Director | Option Exercise | J | 30.00 | 100,000 | 3,000,000 | 0 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Feb 22 2019 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Payment of Exercise | F | 27.00 | 5,763 | 155,601 | 97,198 | 103 K to 97.2 K (-5.60 %) |
| Feb 01 2019 | RARE | Ultragenyx Pharmac ... | SULIMAN SHEHNAAZ | Director | Option Exercise | A | 48.85 | 20,000 | 977,000 | 20,000 | |
| Feb 22 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Payment of Exercise | F | 29.09 | 8,770 | 255,119 | 101,230 | 110 K to 101.2 K (-7.97 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 25,000 | 0 | 110,000 | 85 K to 110 K (+29.41 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 65,000 | 0 | 85,000 | 20 K to 85 K (+325.00 %) |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Option Exercise | A | 31.93 | 170,000 | 5,428,100 | 170,000 | |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Page: 1